Zobrazeno 1 - 10
of 234
pro vyhledávání: '"Naceur-Lombardelli C"'
Autor:
Frankell AM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Dietzen M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Lim EL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Karasaki T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Ward S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Huebner A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Bunkum A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Grigoriadis K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Liu WK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Thol K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Cook DE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bailey C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bentham R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Abbosh C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Nicholson AG; Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK., Le Quesne J; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Pathology Department, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK., Biswas D; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Rosenthal R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Puttick C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hessey S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Lee C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Division of Medicine, University College London, London, UK., Prymas P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Toncheva A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Smith J; Scientific Computing, The Francis Crick Institute, London, UK., Xing W; Scientific Computing, The Francis Crick Institute, London, UK., Nicod J; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Price G; Department of Medical Oncology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK.; University of Aberdeen, Aberdeen, UK., Kerr KM; University of Aberdeen, Aberdeen, UK.; Department of Pathology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK., Naidu B; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Middleton G; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Blyth KG; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Queen Elizabeth University Hospital, Glasgow, UK., Fennell DA; University of Leicester, Leicester, UK.; University Hospitals of Leicester NHS Trust, Leicester, UK., Forster MD; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Lee SM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Falzon M; Department of Cellular Pathology, University College London Hospitals, London, UK., Hewish M; Royal Surrey Hospital, Royal Surrey Hospitals NHS Foundation Trust, Guilford, UK.; University of Surrey, Guilford, UK., Shackcloth MJ; Liverpool Heart and Chest Hospital, Liverpool, UK., Lim E; Academic Division of Thoracic Surgery, Imperial College London, London, UK.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK., Benafif S; Department of Oncology, University College London Hospitals, London, UK., Russell P; Princess Alexandra Hospital, The Princess Alexandra Hospital NHS Trust, Harlow, UK., Boleti E; Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK., Krebs MG; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Lester JF; Singleton Hospital, Swansea Bay University Health Board, Swansea, UK., Papadatos-Pastos D; Department of Oncology, University College London Hospitals, London, UK., Ahmad T; Department of Oncology, University College London Hospitals, London, UK., Thakrar RM; Department of Thoracic Medicine, University College London Hospitals, London, UK.; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Lawrence D; Department of Thoracic Surgery, University College London Hospital NHS Trust, London, UK., Navani N; Department of Thoracic Medicine, University College London Hospitals, London, UK.; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Janes SM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Dive C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK., Blackhall FH; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Summers Y; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Cave J; Department of Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Marafioti T; Department of Cellular Pathology, University College London Hospitals, London, UK., Herrero J; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Peggs KS; Department of Haematology, University College London Hospitals, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Schwarz RF; Institute for Computational Cancer Biology, Center for Integrated Oncology (CIO), Cancer Research Center Cologne Essen (CCCE), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Berlin Institute for the Foundations of Learning and Data (BIFOLD), Berlin, Germany., Van Loo P; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK., Miedema DM; LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark., Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hackshaw A; Cancer Research UK and UCL Cancer Trials Centre, London, UK., Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. m.jamal-hanjani@ucl.ac.uk., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk.
Publikováno v:
Nature [Nature] 2024 Jul; Vol. 631 (8022), pp. E15.
Autor:
Geukens T; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Maetens M; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Hooper JE; Stanford University School of Medicine, Palo Alto, CA, USA., Oesterreich S; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Lee AV; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Miller L; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Atkinson JM; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Rosenzweig M; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Puhalla S; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Thorne H; Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Devereux L; Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Bowtell D; Peter MacCallum Cancer Centre, Melbourne, Australia., Loi S; Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Bacon ER; Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA., Ihle K; Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA., Song M; Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA., Rodriguez-Rodriguez L; Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA., Welm AL; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Gauchay L; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Murali R; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chanda P; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Karacay A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Naceur-Lombardelli C; UCL Cancer Institute, University College London, London, UK., Bridger H; Cancer Research UK, and UCL Cancer Trials Centre, University College London, London, UK., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Kollath L; University of Washington, Seattle, WA, USA., True L; University of Washington, Seattle, WA, USA., Morrissey C; University of Washington, Seattle, WA, USA., Chambers M; University of Washington, Seattle, WA, USA., Chinnaiyan AM; University of Michigan, Ann Arbor, MI, USA., Wilson A; University of Michigan, Ann Arbor, MI, USA., Mehra R; University of Michigan, Ann Arbor, MI, USA., Reichert Z; University of Michigan, Ann Arbor, MI, USA., Carey LA; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Perou CM; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Kelly E; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Maeda D; Department of Molecular and Cellular Pathology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan., Goto A; Department of Cellular and Organ Pathology, Graduate School of Medicine, Akita University, Akita, Japan., Kulka J; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary., Székely B; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.; National Institute of Oncology, Budapest, Hungary., Szasz AM; Division of Oncology, Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary., Tőkés AM; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary., Van Den Bogaert W; Department of Forensic Medicine, University Hospitals Leuven, Leuven, Belgium., Floris G; Department of Pathology, University Hospitals Leuven, Leuven, Belgium., Desmedt C; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
Publikováno v:
The Journal of pathology [J Pathol] 2024 Jun; Vol. 263 (2), pp. 150-165. Date of Electronic Publication: 2024 Mar 29.
Autor:
Hynds RE; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. rob.hynds@ucl.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. rob.hynds@ucl.ac.uk.; Epithelial Cell Biology in ENT Research Group (EpiCENTR), Developmental Biology and Cancer, Great Ormond Street University College London Institute of Child Health, London, UK. rob.hynds@ucl.ac.uk., Huebner A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Pearce DR; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Akarca AU; Department of Cellular Pathology, University College London Hospitals, London, UK., Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Ward S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Gowers KHC; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Al Bakir M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Pich O; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hossain ASMM; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK., Pearce SP; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK., Sivakumar M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Ben Aissa A; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Grönroos E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Chandrasekharan D; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Kolluri KK; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Towns R; Biological Services Unit, University College London, London, UK., Wang K; School of Medicine, University of Leeds, Leeds, UK., Cook DE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bosshard-Carter L; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Rowan AJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Litchfield K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Tumour Immunogenomics and Immunosurveillance Laboratory, University College London Cancer Institute, London, UK., Crosbie PAJ; Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK.; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK., Dive C; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK., Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Janes SM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Marafioti T; Department of Cellular Pathology, University College London Hospitals, London, UK., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2024 May 31; Vol. 15 (1), pp. 4653. Date of Electronic Publication: 2024 May 31.
Autor:
Frankell, A.M., Dietzen, M., Al Bakir, M., Lim, E.L., Karasaki, T., Ward, S., Veeriah, S., Colliver, E., Huebner, A., Bunkum, A., Hill, M.S., Grigoriadis, K., Moore, D.A., Black, J.R.M., Liu, W.K., Thol, K., Pich, O., Watkins, T.B.K., Naceur-Lombardelli, C., Cook, D.E., Salgado, R., Wilson, G.A., Bailey, C., Angelova, M., Bentham, R., Martínez-Ruiz, C., Abbosh, C., Nicholson, A.G., Le Quesne, J., Biswas, D., Rosenthal, R., Puttick, C., Hessey, S., Lee, C., Prymas, P., Toncheva, A., Smith, J., Xing, W., Nicod, J., Price, G., Kerr, K.M., Naidu, B., Middleton, G., Blyth, K.G., Fennell, D.A., Forster, M.D., Lee, S.M., Falzon, M., Hewish, M., Shackcloth, M.J., Lim, E., Benafif, S., Russell, P., Boleti, E., Krebs, M.G., Lester, J.F., Papadatos-Pastos, D., Ahmad, T., Thakrar, R.M., Lawrence, D., Navani, N., Janes, S.M., Dive, C., Blackhall, F.H, Summers, Y., Cave, J., Marafioti, T., Herrero, J., Quezada, S.A., Peggs, K.S., Schwarz, R.F., Van Loo, P., Miedema, D.M., Birkbak, N.J., Hiley, C.T., Hackshaw, A., Zaccaria, S., Jamal-Hanjani, M., McGranahan, N., Swanton, C.
Lung cancer is the leading cause of cancer-associated mortality worldwide. Here we analysed 1,644 tumour regions sampled at surgery or during follow-up from the first 421 patients with non-small cell lung cancer prospectively enrolled into the TRACER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::ef45f584564f3d0f221808d502071a8b
http://edoc.mdc-berlin.de/23266/5/23266suppl.zip
http://edoc.mdc-berlin.de/23266/5/23266suppl.zip
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Spain L; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Department of Medical Oncology, Peter MacCallum Cancer -Centre, Melbourne, Australia., Coulton A; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Tumour Immunogenomics and Immunosurveillance (TIGI) Lab, UCL Cancer Institute, London, United Kingdom., Lobon I; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom., Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Schnidrig D; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom., Shepherd STC; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Shum B; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Byrne F; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom., Goicoechea M; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom., Piperni E; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom., Au L; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Department of Medical Oncology, Peter MacCallum Cancer -Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Edmonds K; The Royal Marsden Hospital, London, United Kingdom., Carlyle E; The Royal Marsden Hospital, London, United Kingdom., Hunter N; The Royal Marsden Hospital, London, United Kingdom., Renn A; The Royal Marsden Hospital, London, United Kingdom., Messiou C; The Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, Kensington and Chelsea, United Kingdom., Hughes P; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Nobbs J; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Foijer F; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., van den Bos H; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., Wardenaar R; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., Spierings DCJ; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., Spencer C; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Schmitt AM; The Royal Marsden Hospital, London, United Kingdom., Tippu Z; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Lingard K; The Royal Marsden Hospital, London, United Kingdom., Grostate L; The Royal Marsden Hospital, London, United Kingdom., Peat K; The Royal Marsden Hospital, London, United Kingdom., Kelly K; The Royal Marsden Hospital, London, United Kingdom., Sarker S; The Royal Marsden Hospital, London, United Kingdom., Vaughan S; The Royal Marsden Hospital, London, United Kingdom., Mangwende M; The Royal Marsden Hospital, London, United Kingdom., Terry L; The Royal Marsden Hospital, London, United Kingdom., Kelly D; The Royal Marsden Hospital, London, United Kingdom., Biano J; The Royal Marsden Hospital, London, United Kingdom., Murra A; The Royal Marsden Hospital, London, United Kingdom., Korteweg J; The Royal Marsden Hospital, London, United Kingdom., Lewis C; The Royal Marsden Hospital, London, United Kingdom., O'Flaherty M; The Royal Marsden Hospital, London, United Kingdom., Cattin AL; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom., Emmerich M; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; St. John's Institute of Dermatology, Guy's and St Thomas' Hospital NHS Foundation Trust, London, United Kingdom., Gerard CL; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Precision Oncology Center, Oncology Department, Lausanne University Hospital, Lausanne, Switzerland., Pallikonda HA; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom., Lynch J; The Royal Marsden Hospital, London, United Kingdom., Mason R; Gold Coast University Hospital, Queensland, Australia., Rogiers A; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Xu H; The Francis Crick Institute, London, United Kingdom., Huebner A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom., McGranahan N; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom., Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom., Murai J; Tumour Immunogenomics and Immunosurveillance (TIGI) Lab, UCL Cancer Institute, London, United Kingdom.; Drug Discovery Technology Laboratories, Ono Pharmaceutical Co., Ltd. Osaka, Japan., Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom., Borg E; University College London Hospital, London, United Kingdom., Mitchison M; University College London Hospital, London, United Kingdom., Moore DA; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Falzon M; University College London Hospital, London, United Kingdom., Proctor I; University College London Hospital, London, United Kingdom., Stamp GWH; The Francis Crick Institute, London, United Kingdom., Nye EL; The Francis Crick Institute, London, United Kingdom., Young K; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Furness AJS; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.; The Institute of Cancer Research, Kensington and Chelsea, United Kingdom., Pickering L; The Royal Marsden Hospital, London, United Kingdom., Stewart R; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Mahadeva U; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Green A; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Larkin J; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Litchfield K; Tumour Immunogenomics and Immunosurveillance (TIGI) Lab, UCL Cancer Institute, London, United Kingdom., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, United Kingdom.; Department of Medical Oncology, University College London Hospitals, London, United Kingdom., Turajlic S; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Publikováno v:
Cancer discovery [Cancer Discov] 2023 Jun 02; Vol. 13 (6), pp. 1364-1385.
Autor:
Al Bakir M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Huebner A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Grigoriadis K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Ward S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Laycock J; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Johnson D; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Razaq M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Akther M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Prymas P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Toncheva A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hessey S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Dietzen M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Frankell AM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bunkum A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Lim EL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Abbosh C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hiley CT; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Cook DE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Nye E; Experimental Histopathology, The Francis Crick Institute, London, UK., Stone RK; Experimental Histopathology, The Francis Crick Institute, London, UK., Fennell DA; University of Leicester, Leicester, UK.; University Hospitals of Leicester NHS Trust, Leicester, UK., Price G; Department of Medical Oncology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK.; University of Aberdeen, Aberdeen, UK., Kerr KM; University of Aberdeen, Aberdeen, UK.; Department of Pathology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK., Naidu B; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK., Middleton G; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Summers Y; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Lindsay CR; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Blackhall FH; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Cave J; Department of Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Blyth KG; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Beatson Institute, Glasgow, UK.; Queen Elizabeth University Hospital, Glasgow, UK., Nair A; Department of Radiology, University College London Hospitals, London, UK.; UCL Respiratory, Department of Medicine, University College London, London, UK., Ahmed A; Department of Radiology, University College London Hospitals, London, UK., Taylor MN; Department of Radiology, University College London Hospitals, London, UK., Procter AJ; Department of Radiology, University College London Hospitals, London, UK., Falzon M; Department of Cellular Pathology, University College London Hospitals, London, UK., Lawrence D; Department of Thoracic Surgery, University College London Hospital NHS Trust, London, UK., Navani N; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.; Department of Thoracic Medicine, University College London Hospitals, London, UK., Thakrar RM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.; Department of Thoracic Medicine, University College London Hospitals, London, UK., Janes SM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Papadatos-Pastos D; Department of Oncology, University College London Hospitals, London, UK., Forster MD; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Lee SM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Ahmad T; Department of Oncology, University College London Hospitals, London, UK., Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Peggs KS; Department of Haematology, University College London Hospitals, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dive C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK., Hackshaw A; Cancer Research UK & UCL Cancer Trials Centre, London, UK., Birkbak NJ; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark., Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. m.jamal-hanjani@ucl.ac.uk., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Charles.Swanton@crick.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. Charles.Swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. Charles.Swanton@crick.ac.uk.
Publikováno v:
Nature [Nature] 2023 Apr; Vol. 616 (7957), pp. 534-542. Date of Electronic Publication: 2023 Apr 12.
Autor:
Al-Sawaf O; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Weiss J; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Diagnostic and Interventional Radiology, University Freiburg, Freiburg, Germany., Skrzypski M; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland., Lam JM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Zambrana F; Infanta Sofía University Hospital, Madrid, Spain., Kidd AC; Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, UK., Frankell AM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Watkins TBK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Puttick C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Huebner A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Bakir MA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Sokač M; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark., Collins S; Early Clinical Development, Pfizer UK Ltd, Cambridge, UK., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Magno N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Prymas P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Toncheva A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Ward S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Jayanth N; Cancer Research UK & UCL Cancer Trials Centre, London, UK., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia., Bridge CP; MGH & BWH Center for Clinical Data Science, Boston, MA, USA., Christiani DC; Department of Medicine, Massachusetts General Hospital/Harvard Medicine School, and Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Mak RH; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Bay C; Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA., Rosenthal M; Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA., Sattar N; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK., Welsh P; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK., Liu Y; Department of Genetics, Harvard Medical School, Boston, USA.; Howard Hughes Medical Institute, Harvard Medical School, Boston, USA., Perrimon N; Department of Genetics, Harvard Medical School, Boston, USA.; Howard Hughes Medical Institute, Harvard Medical School, Boston, USA., Popuri K; Department of Computer Science, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Burnaby, Canada., Beg MF; School of Engineering Science, Simon Fraser University, Burnaby, British Colombia, Canada., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hackshaw A; Cancer Research UK & UCL Cancer Trials Centre, London, UK., Breen DM; Internal Medicine Research Unit, Pfizer, Cambridge, MA, USA., O'Rahilly S; Wellcome Trust-MRC Institute of Metabolic Science and NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK., Birkbak NJ; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark., Aerts HJWL; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, The Netherlands., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. m.jamal-hanjani@ucl.ac.uk., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Charles.swanton@crick.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. Charles.swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. Charles.swanton@crick.ac.uk.
Publikováno v:
Nature medicine [Nat Med] 2023 Apr; Vol. 29 (4), pp. 846-858. Date of Electronic Publication: 2023 Apr 12.
Autor:
Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Puttick C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK., Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK., Demeulemeester J; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Integrative Cancer Genomics Laboratory, Department of Oncology, KU Leuven, Leuven, Belgium.; VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium., Larose Cadieux E; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Medical Genomics, University College London Cancer Institute, London, UK., Thol K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Jones TP; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Toncheva A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Prymas P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK., Ward S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Cubitt L; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Athanasopoulou F; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK., Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK., Castignani C; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Medical Genomics, University College London Cancer Institute, London, UK., Dietzen M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK., Huebner A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK., Al Bakir M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK., Tanić M; Medical Genomics, University College London Cancer Institute, London, UK.; Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK., Lim EL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK., Al-Rashed AM; Centre for Nephrology, Division of Medicine, University College London, London, UK., Lang D; Scientific Computing STP, Francis Crick Institute, London, UK., Clements J; Scientific Computing STP, Francis Crick Institute, London, UK., Cook DE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK., Rosenthal R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK., Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK., Frankell AM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK., de Carné Trécesson S; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., East P; Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK., Kanu N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Litchfield K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Tumour Immunogenomics and Immunosurveillance Laboratory, University College London Cancer Institute, London, UK., Birkbak NJ; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark., Hackshaw A; Cancer Research UK & UCL Cancer Trials Centre, London, UK., Beck S; Medical Genomics, University College London Cancer Institute, London, UK., Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Charles.Swanton@crick.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK. Charles.Swanton@crick.ac.uk.; Department of Medical Oncology, University College London Hospitals, London, UK. Charles.Swanton@crick.ac.uk., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.
Publikováno v:
Nature [Nature] 2023 Apr; Vol. 616 (7957), pp. 543-552. Date of Electronic Publication: 2023 Apr 12.